Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2023 · 10-Q
Revenue$271.58M$271.58M+0.9% vs Q2 2022 Net Income$50.01M$50.01M−37.6% vs Q2 2022 EPS Diluted$0.31$0.31−36.7% vs Q2 2022 Gross Profit$183,360,000−0.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$64,384,000−36.2% Free Cash Flowderived$58,275,000−35.8% Margins · derivedGross margin67.5%−0.7 pt vs Q2 2022
Operating margin25.0%+1.8 pt vs Q2 2022
Net margin18.4%−11.4 pt vs Q2 2022
ended Dec 31, 2022 · filed Feb 7, 2023 · 38 d after period end